#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER2-negative metastatic breast cancer

Documenti analoghi

• First study of the supernova remnant population in the Large Magellanic Cloud with eROSITA
  di: Zangrandi Federico, et al.
  Pubblicazione: (2026-05-01)
• A complete X-ray view of supernova remnant W28 with the Einstein Probe: Spatial distribution of parameters, and the origin of the thermal-composite morphology
  di: Chi Yi-Heng, et al.
  Pubblicazione: (2026-05-01)
• Acceleration of cosmic rays at the post-adiabatic shocks of supernova remnants
  di: Petruk O., et al.
  Pubblicazione: (2026-05-01)
• Searching for New Supernova Remnant Candidates from the VTSS Survey
  di: Elif Beklen
  Pubblicazione: (2022-12-01)
• eROSITA and STAPS study of the Antlia supernova remnant
  di: Knies F., et al.
  Pubblicazione: (2026-04-01)